Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a <i>KRAS</i> G12C Mutation: A Real-World Study.

J Clin Med · 2022 · PMC9324356 · PMID 35887862

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

A nonsignificant trend for worse survival was also observed for patients with a TP53 or STK11 co-mutation.

also in 5,406 other papers

a possible trendno p-value reported

The presence of a TP53 co-mutation showed a possible trend for predicting shorter OS, but without statistical significance ( p = 0.068).

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.